t - 医索

找到约 9305 条结果

SACI-0 HR A randomized phase ll trial ofsacituzumab govitecan with or without pembrolizumabin patients with metastatic hormone receptor-positive!HER2-negative breast cancer

医客学院 - 会议报告集

Racial differences in genomic profilesand targeted treatment use in ER HER2-metastatic breast cancer

医客学院 - 会议报告集

Primary results from PATRICIA Cohort c (SOLTI-1303)a randomized phase ll study evaluating palbociclib withtrastuzumab and endocrine therapy in pretreated HER2.positive and PAM50 luminal advanced b

医客学院 - 会议报告集

Outcomes of Advanced MetastaticBreast Cancer(aMBC) Treated with Bria-lMT, an Allogeneic Whole-cell Immunotherapy

医客学院 - 会议报告集

LBA1000 DESTINY-Breast06

医客学院 - 会议报告集

H3B-6545 in women with locally advancedmetastaticestrogen receptor-positive,HER2-negative breast cancer

医客学院 - 会议报告集

Genomic and Tumor MicroenvironmentDynamics of Brain Metastases in BreastCancer

医客学院 - 会议报告集

First-line inavolisibplacebo palbociclib fulvestrant(InavoPbo Palbo Fulv) in patients (pts) with PiK3cA-mutated.hormone receptor-positive, HER2-negative locally advancedmetastaticbreast cancer

医客学院 - 会议报告集

Exploring New Partnerships in HER2-Positive Breast Cancer

医客学院 - 会议报告集

Enfortumab Vedotin in the HR HER2-and Triple-Negative Breast CancerCohorts of EV-202

医客学院 - 会议报告集

今日实时热搜